Omar Hamid, MD

home / authors / omar-hamid-md

Chief, Translational Research and Immunotherapy, director, Melanoma Therapeutics, director, Melanoma Center and Phase I Immuno-Oncology Program, The Angeles Clinic and Research Institute

Articles

Omar Hamid, MD

Integrating TIL-Based Therapy into Melanoma Treatment: Omar Hamid, MD

October 1st 2021

The chief of translational Research and immunotherapy at The Angeles Clinic and Research Institute discussed the integration of tumor infiltrating lymphocyte–based therapy into the melanoma armamentarium.

© 2024 MJH Life Sciences

All rights reserved.